. Effect of I-aminocyclopentane-I -carboxylic acid on the transfer of methyl groups from S-adenosyl[methyl-"Clmethionine
and [methyl-'4Clmethionine to myelin basic protein by mouse spinal-cord enzymes
The results presented are calculated by dividing the radioactivity incorporated into precipitated protein in the presence of inhibitor by the radioactivity incorporated in the absence of inhibitor.
[ I-Aminocyclopentane-I-carboxylic acid1 by the decrease in incorporation of labelled methyl groups from enzymically synthesized S-adenosylmethionine into basic protein by spinal-cord protein methylase activity (Table 1) . Electrophoresis of the labelled protein precipitate on acetic acidhrea-polyacrylamide gels (Deibler et al., 1972) , followed by autoradiography of the gels, indicated that only the myelin basic protein was detectably labelled. Autoradiography of peptide 'maps' of labelled peptides obtained by digestion with trypsin (Bates ef al., 1975) demonstrated that radiolabel was incorporated into the peptide containing arginine-107 (Eylar et al., 1971) .
These results have demonstrated the activity of methionine adenosyltransferase and protein (arginine) methyltransferase activity in the cytoplasmic fraction of mouse spinal cord. The protein (arginine) methyltransferase appears to have a specificity for arginine-107 of myelin basic protein from bovine spinal cord. This observation is in accord with results obtained with guinea-pig enzyme and human myelin basic protein acceptor (Baldwin & Carnegie, 1971) and suggests that specific structural features of myelin basic protein in the region of arginine-107 are similar in a number of species. The inhibition of myelin basic protein arginine methylase by inhibiting the synthesis of S-adenosylmethionine with 1-aminocyclopentane-1-carboxylic acid indicates that the details of this particular post-translational modification may now be investigated both in virro and in vivo. Ethanolamine plasmalogen (2-acyl-1-alk-1 '-enyl-sn-glycero-3-phosphoethanolamine) is the major phospholipid component of myelin. Like other phospholipids of the myelin sheath, plasmalogens are continuously being replaced within the myelin membrane. For phospholipids other than ethanolamine phospholipids, this could involve phospholipid-exchange proteins. For ethanolamine phospholipids the mechanism of turnover is unknown, nor the regulation of the biosynthetic and degradative pathways. The activity of plasmalogenase (2-acyl-1 -alk-1'-enyl sn-glycero-3-phosphoethanolamine aldehydohydrolase, EC 3.3.2.-), which cleaves the vinyl ether bond of plasmalogens, actually increases at the time of myelin membrane deposition in the brain (Ansell, 1971) . It has also been reported to be increased in active areas of demyelination within the brain (Ansell & Spanner, 1968) . Plasmalogenase activity is probably conlined to the myelin-producing oligodendroglial cell, and has low activity in neutrons and astrocytes (Dorman ef al., 1977) .
The two methods that have been most commonly employed , for the determination of plasmalogenase activity require large amounts of protein and lipid substrate and are laborious to perform. They involve extraction of lipid from the assay mixture and determination of the plasmalogen remaining either by reacting the vinyl ether group with an iodine solution (Williams et al., 1962) or by measuring the disappearance of plasmalogen by determination of phospholipid phosphorus of lipid products separated by t.1.c. (D'Amato et al., 1975) . A rapid continuous spectrophotometric assay of plasmalogenase has now been devised that has the sensitivity for use with small amounts of isolated nerve cells and subcellular fractions. The long-chain fatty aldehydes, produced from plasmalogen vinyl ether bond cleavage, are converted into the corresponding alcohols by added liver alcohol dehydrogenase, with the concomitant oxidation of N ADH. Liver alcohol dehydrogenase has activity towards longer-chain aldehydes, though less than with acetaldehyde.
Oligodendroglia were isolated from white matter dissected from the cerebral cortex of bovine brain. Cells were disrupted by sonication for 10s at 80W in a Branson sonicator. Purified ethanolamine plasmalogen was dispersed in IOOmM-Tris/HCl buffer (pH7.4)/0.5% Triton X-100, to a final concentration of 2 . 4 m~, by sonication at 80W until a clear solution was 590th MEETING, SHEFFIELD obtained (1-2min at OOC). The plasmalogen substrate was prepared fresh before assay of the enzyme activity.
Each assay mixture contained (in 1.Oml final volume) 50-5OOpg of glial-cell-homogenate protein, 1 mM-dithiothreitol, ~O O~M -N A D H , 0.3 unit (nominal activity in a standard assay; lOOpg of protein) of horse liver alcohol dehydrogenase (Boehringer Mannheim) and lOOmM-Tris/HCl buffer, pH 7.4. After preincubation at 37OC, 120nmol of ethanolamine plasmalogen was added (giving a concentration of Triton X-100 of 0.025% in the assay mixture), and the initial rate was measured at 340nm over a 5 min period. Control incubation mixtures contained all the components except plasmalogen, but with the addition of 0.5% Triton X-100 (Cr200pl. equivalent to the volume of the plasmalogen solution added). Control incubations were carried out concurrently. Endogenous oxidation of NADH by the cell suspension was determined in the absence of added plasmalogen and alcohol dehydrogenase.
The rate of the reaction was linear for up to 10-15nmol of NADH oxidized (equivalent to about 15% substrate utilization). The long-chain alcohols produced are probably inhibitory towards alcohol dehydrogenase. The initial rate of reaction was proportional to the amount of glial-cell protein added up to 500pg. The plasmalogen concentration used in the standard assay was not optimum. Higher concentrations shortened the time over which the initial reaction rate was linear, decreasing the accuracy of measurement. Dorman et al. (1977) obtained higher specific activities for isolated bovine glia, but used plasmalogen concentrations 10-fold higher than in the present study.
Plasmalogenase activity has been reported to be influenced by bivalent cations (Ansell & Spanner, 1965) . However, the addition of 10rnM-MgC1, did not increase the rate of reaction. With plasmalogen dispersed in 0.5% sodium deoxycholate, Mg2+ caused precipitation of the detergent.
In terms of substrate specificity, the plasmalogenase was only half as active towards lysoplasmalogen (after removal of the acyl group) compared with the acylalkenyl-plasmalogen in isolated glial homogenates. From work with acetone-extracted brain powders, Ansell & Spanner (1965) also suggested that the alkenyl group is removed first, followed by the acyl group, by phopholipase A.
Plasmalogenase has been reported to be present in microsoma1 membranes and mitochondria from whole brain (Ansell & Spanner, 1968) but absent from myelin. The assay method described in the present communication has enabled the subcellular distribution of plasmalogenase in a number of membrane fractions derived from isolated oligodendroglia to be determined, and the use of plasmalogenase as an enzyme 'marker' for oligodendroglia. Although cyclic AMP is reported to inhibit protein synthesis in several tissues, including liver and muscle (Bloxham & Akhtar, 19791 , little information is available about the effects of this compound on total protein synthesis in brain. However, Boksay et al. (1976) report that the phosphodiesterase inhibitor pentoxifylline decreases incorporation of precursor amino acid into protein in brain cell suspensions. In view of interest in the therapeutic potential of phosphodiesterase inhibitors (Amer & Kreighbaum, 1975) , we have compared the effects of cyclic AMP itself and of selected phosphodiesterase inhibitors on incorporation of L-[U-*'Cllysine into protein of rat brain and liver slices. We have also measured the tissue contents of cyclic AMP and ATP.
Brain slices (0.3mm thickness) were prepared from female Wistar rats (200-25Og body wt.) and preincubated for 1 h to decrease endogenous cyclic nucleotide contents. Slices were
